99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis
NCT05859763 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2023-05-16
Summary
This prospective study will investigate the potential usefulness of 99mTc labeled FAPI SPECT/CT in the diagnosis, treatment response assessment, and follow-up of pulmonary fibrosis.
Conditions
Interventions
- DRUG
-
99mTc-HFAPI
Each patient receive a intravenous injection of 99mTc-HFAPI, and undergo SPECT/CT scan within specified time.
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-12
- Primary Completion
- 2023-07-01
- Completion
- 2024-07-01
Countries
- China
Study Locations
More Related Trials
-
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease
NCT06143540 ·Status: RECRUITING
-
FAPI PET for Lung Fibrosis
NCT05365802 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
NCT05420558 ·Status: UNKNOWN
-
Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors
NCT04554719 ·Status: UNKNOWN ·Phase: NA
-
FAPI PET/CT in Various FAP-Related Disease Patients
NCT06688071 ·Status: RECRUITING
-
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
NCT06270394 ·Status: COMPLETED ·Phase: NA
-
FAPI-74 PET/CT in Adults With Fibrosis
NCT06413355 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of 18F-FAPI-RGD in Breast Tumors
NCT05976620 ·Status: COMPLETED
-
68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma
NCT05275985 ·Status: UNKNOWN ·Phase: NA
-
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
NCT06438705 ·Status: RECRUITING
-
Study on c-Met Targeted PET/CT Imaging in NSCLC
NCT06911697 ·Status: RECRUITING ·Phase: NA
-
Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI
NCT05400967 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease
NCT06359795 ·Status: RECRUITING ·Phase: NA
-
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
A Study on the Diagnostic Value of 99mTc-FAPI Quantitative SPECT/CT Imaging in Adult Solitary Bone Lesions
NCT07114211 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
NCT06937112 ·Status: RECRUITING
-
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
NCT06563765 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
NCT06151119 ·Status: RECRUITING
-
[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity
NCT05806333 ·Status: UNKNOWN ·Phase: NA
-
Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
NCT06940427 ·Status: RECRUITING ·Phase: PHASE2
-
TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors
NCT06755086 ·Status: NOT_YET_RECRUITING
-
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
NCT01109953 ·Status: TERMINATED
-
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
NCT06164561 ·Status: RECRUITING